Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IDP-001 in Advanced or Metastatic Solid Tumors
NCT07602842Phase 2Recruiting
- Sponsor
- InduPro
- Start
- Jul 2026
- Primary completion
- Jun 2028
- Modality
- Bispecific Antibodies, Antibody-Drug Conjugates (ADCs)
- Countries
- 1
01
Overview
A Phase 2 trial of IDP-001 in solid tumor, squamous cell carcinoma of the lung (LSCC), non-small cell lung cancer (NSCLC), head and neck squamous cell carcinoma (HNSCC), cutaneous squamous cell carcinoma (cSCC), sponsored by InduPro. Started Jul 2026; status: recruiting.
02
Drugs
IDP-001
03
Conditions
solid tumorsquamous cell carcinoma of the lung (LSCC)non-small cell lung cancer (NSCLC)head and neck squamous cell carcinoma (HNSCC)cutaneous squamous cell carcinoma (cSCC)
Beyond the preview
Go deeper on NCT07602842.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07602842.